1. Home
  2. TECX vs VREX Comparison

TECX vs VREX Comparison

Compare TECX & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • VREX
  • Stock Information
  • Founded
  • TECX 2019
  • VREX 2016
  • Country
  • TECX United States
  • VREX United States
  • Employees
  • TECX N/A
  • VREX N/A
  • Industry
  • TECX
  • VREX Industrial Machinery/Components
  • Sector
  • TECX
  • VREX Technology
  • Exchange
  • TECX Nasdaq
  • VREX Nasdaq
  • Market Cap
  • TECX 334.4M
  • VREX 297.3M
  • IPO Year
  • TECX 2018
  • VREX N/A
  • Fundamental
  • Price
  • TECX $19.76
  • VREX $6.88
  • Analyst Decision
  • TECX Buy
  • VREX Strong Buy
  • Analyst Count
  • TECX 6
  • VREX 2
  • Target Price
  • TECX $72.40
  • VREX $22.50
  • AVG Volume (30 Days)
  • TECX 203.0K
  • VREX 555.0K
  • Earning Date
  • TECX 05-08-2025
  • VREX 05-08-2025
  • Dividend Yield
  • TECX N/A
  • VREX N/A
  • EPS Growth
  • TECX N/A
  • VREX N/A
  • EPS
  • TECX N/A
  • VREX N/A
  • Revenue
  • TECX N/A
  • VREX $827,500,000.00
  • Revenue This Year
  • TECX N/A
  • VREX $4.16
  • Revenue Next Year
  • TECX N/A
  • VREX $3.71
  • P/E Ratio
  • TECX N/A
  • VREX N/A
  • Revenue Growth
  • TECX N/A
  • VREX N/A
  • 52 Week Low
  • TECX $1.40
  • VREX $6.97
  • 52 Week High
  • TECX $61.07
  • VREX $17.46
  • Technical
  • Relative Strength Index (RSI)
  • TECX 49.14
  • VREX 32.29
  • Support Level
  • TECX $17.56
  • VREX $8.09
  • Resistance Level
  • TECX $21.99
  • VREX $8.71
  • Average True Range (ATR)
  • TECX 1.96
  • VREX 0.54
  • MACD
  • TECX 0.21
  • VREX 0.11
  • Stochastic Oscillator
  • TECX 46.15
  • VREX 5.71

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About VREX Varex Imaging Corporation

Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.

Share on Social Networks: